1 December 2024 in Journal of Clinical and Analytical Medicine
Aim It was aimed to measure the levels of the heat shock proteins 27 and 60 as mediators to show hypoxia and tissue injury in thalassemia major and thalassemia intermedia patients followed in our clinic. Methods 53 patients who had the diagnosis of thalassemia major (n = 38) and thalassemia intermediate (n = 15) and who presented to the Department of Pediatric Hematology at Gaziantep University were evaluated. 50 healthy children aged between 1-16 attending to general pediatric examination for routine control were taken as a control group (n = 50). The relationship between clinical findings and laboratory parameters, and HSP 27 and HSP 60 were evaluated. Results The mean age was 9.2 ± 4.4 years in thalassemia major patients, 5.6 ± 3.8 years in thalassemia intermediate patients and 9.1 ± 3.7 years in control group patients. The level of HSP 27 was 5 ± 3 in thalassemia major, 4.2 ± 1.7 in thalassemia intermediate, 0.93 ± 0.76 in control group and the difference between patients and control group was significant (P < .05). When the splenectomy status and HSP levels of the patients were compared, HSP 27 level was 7.5 ± 5 in patients who had undertaken splenectomy and was 3.7 ± 2.4 in patients who had not undertaken splenectomy and it was statistically significant (P < .05). HSP 60 levels were 13.6 ± 20 in patients who had undertaken splenectomy and were 8.3 ± 32.4 in patients who had not undertaken splenectomy and it was statistically significant. Conclusion Measuring HSP 27 and HSP 60 levels could be used as evaluation criteria in following of thalassemia major and in thalassemia intermediate patients the evaluation of complications.